|
TMEM57 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.02999999998621E-06 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.18810000000614E-05 |
| Normal-vs-Stage2 |
4.96859999998822E-06 |
| Normal-vs-Stage3 |
1.232570E-04 |
| Normal-vs-Stage4 |
3.9124000000057E-05 |
| Stage1-vs-Stage2 |
1.506010E-01 |
| Stage1-vs-Stage3 |
3.677200E-01 |
| Stage1-vs-Stage4 |
1.526210E-02 |
| Stage2-vs-Stage3 |
5.120800E-01 |
| Stage2-vs-Stage4 |
8.195000E-01 |
| Stage3-vs-Stage4 |
3.099400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.15149999999365E-06 |
| Normal-vs-AfricanAmerican |
4.56910000001809E-06 |
| Normal-vs-Asian |
3.358400E-02 |
| Caucasian-vs-AfricanAmerican |
4.317200E-01 |
| Caucasian-vs-Asian |
9.481600E-01 |
| AfricanAmerican-vs-Asian |
6.990800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.65749999964704E-07 |
| Normal-vs-Female |
6.120000E-03 |
| Male-vs-Female |
3.812000E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.304400E-03 |
| Normal-vs-Extreme_Weight |
3.16079999995722E-06 |
| Normal-vs-Obese |
7.74610000000564E-05 |
| Normal-vs-Extreme_Obese |
7.98320000000574E-05 |
| Normal_Weight-vs-Extreme_Weight |
4.881000E-01 |
| Normal_Weight-vs-Obese |
8.054200E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.455230E-01 |
| Extreme_Weight-vs-Obese |
5.802000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.556200E-01 |
| Obese-vs-Extreme_Obese |
2.315000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.229400E-04 |
| Normal-vs-Age(41-60Yrs) |
5.981400E-04 |
| Normal-vs-Age(61-80Yrs) |
8.68300000012034E-07 |
| Normal-vs-Age(81-100Yrs) |
7.80290000000905E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.648800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.224400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.917210E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.075800E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.860300E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.961400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.966000E-04 |
| Normal-VS-Type2 PRCC |
8.33679999479031E-08 |
| Normal-VS-KIRP CIMP |
3.91149999999785E-05 |
| Normal-VS-Unclassified PRCC |
2.323400E-03 |
| Type1 PRCC-VS-Type2 PRCC |
5.046200E-04 |
| Type1 PRCC-VS-KIRP CIMP |
6.498100E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
6.496800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
8.094800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
5.550300E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
5.756300E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.94269999992991E-07 |
| Normal-vs-N1 |
1.03890000002771E-06 |
| Normal-vs-N2 |
5.834400E-04 |
| N0-vs-N1 |
5.968000E-01 |
| N0-vs-N2 |
2.319000E-01 |
| N1-vs-N2 |
2.747800E-01 |
|
|
